OIG report recommends 9% cut in EPO reimbursement.
Neumann
M E
ME
D016527:Drug Costs; D004921:Erythropoietin; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D011057:Politics; D006435:Renal Dialysis / Q000191:economics*; D014481:United States
D004921:Erythropoietin